Pfizer (NYSE:PFE)

Prescription Drugs, Pills

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Dollar Sign Island

20 Companies Buying Back the Most Stock in 2016

It is no secret that investors love dividends and stock buybacks. In recent years, there has been a larger shift into companies buying back shares of common stock, even while they ...
Read Full Story »
Quotes

The 4 Stocks That Lifted the Dow on Tuesday

June 21, 2016: Markets opened higher again Tuesday ahead of Fed chairwoman Janet Yellen's appearance on Capitol Hill. The odds continue to improve that British voters will not choose to ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour, US Foods and More

The stock market was indicated handily higher on Monday, negating most of last week's major drop. Is the trend of buying the dips already coming back into play that fast? ...
Read Full Story »
thinkstockphotos-522646895

The 4 Stocks That Tanked the Dow on Friday

June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be ...
Read Full Story »
market crash

The 4 Stocks That Weighed on the DJIA Wednesday

June 15, 2016: Markets opened higher Wednesday on hopes that the the FOMC meeting would leave interest rates unchanged, the outcome most people expected and the actual outcome as it ...
Read Full Story »
Pills and tablets

Pfizer and Shire Move on IBD License Agreement

Pfizer Inc. (NYSE: PFE) made waves early on Tuesday after the announcement of its newest licensing deal. Shire PLC (NASDAQ: SHPG) announced it has agreed to license global rights to all indications ...
Read Full Story »
Medicine pills

Major Pharma Has Short Sellers on the Run

The short interest data have been released for the May 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
thinkstockphotos-522646895

The 4 Stocks That Boosted the Dow Wednesday

June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a falling dollar. An premarket jump in shares of LendingClub helped ...
Read Full Story »
Female patient on gurney

Merrill Lynch Picks ASCO Winners

The health care sector is descending on Chicago as the American Society of Clinical Oncology (ASCO) annual meeting nears. This meeting draws many companies and analysts alike, looking for the ...
Read Full Story »
Doctor, Health (pulse) copy

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is in the process of gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their ...
Read Full Story »
Pfizer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Needless to say, the health care sector, especially pharmaceuticals and biotech, have taken a rhetorical beating from politicians looking to force the blame for high drug prices on some of the ...
Read Full Story »
white pills

Short Sellers Take Mixed Stance on Major Pharma

The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
ThinkstockPhotos-481735362

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

As the time of “sell in May and go away” arrived, it seems the short sellers were neither strongly for nor against the notion, as least as far as the ...
Read Full Story »
graph

8 Stocks on the Move After ASCO Cancer Abstracts

The American Society of Clinical Oncology (ASCO) is in the process of setting up for its annual meeting in Chicago. In this meeting, companies and cancer drug developers will share ...
Read Full Story »